In-Vivo Automated Diabetes Control System Utilizing Molecular Communication

The management of glucose levels in type I diabetes patients is a tedious daily routine that comprises painful glucose measurements and insulin shots. The process is also intractable as insulin is administered in fixed doses, leading sometimes to hypo-glycemia. To address these limitations, this paper conceptualizes an in-vivo glucose control mechanism that relies on subcutaneous glucose measurement to trigger the release of precise doses of insulin into the bloodstream. The signalling process is achieved through a molecular communication system where information is encoded in molecules. The implementation of the proposed concept would eventually revolutionize diabetes management to a painless and more accurate approach.